| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e0d0ee35d4a877b3c8fffe658303ee3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260a2422f673ee8f0afdf10e2fb9745f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc828d701721eee234295d506297ab1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274b5fb106b865980adfb79e8daae9b8 |
| publicationDate |
2012-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2374648-T3 |
| titleOfInvention |
COMPOSITIONS OF LIPOSOMIC VACCINES THAT INCLUDE A POLISACARIUM ANTIGEN AND A PROTEIN ASSISTANT. |
| abstract |
A liposomal composition comprising a polysaccharide antigen and a protein carrier coated in the intravesicular space of liposomes. Where the polysaccharide antigen is soluble in water and the protein carrier has at least one T-cell epitope, a molecular weight of at least 35 kDa, it is non-toxic and is selected from the tetanus toxoid and the diphtheria toxoid; Where the polysaccharide antigen and the protein carrier are unconjugated; and the liposomes have an average diameter in the range of 50-700 nm and are formed of liposomes that form compounds that do not have, in combination, total ionic charge and comprise at least one phospholipid. |
| priorityDate |
2005-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |